140 related articles for article (PubMed ID: 10487519)
1. Conversion of C57Bl/6 mice from a tumor promotion-resistant to a -sensitive phenotype by enhanced ornithine decarboxylase expression.
Guo Y; Zhao J; Sawicki J; Peralta Soler A; O'Brien TG
Mol Carcinog; 1999 Sep; 26(1):32-6. PubMed ID: 10487519
[TBL] [Abstract][Full Text] [Related]
2. Haploinsufficiency for odc modifies mouse skin tumor susceptibility.
Guo Y; Cleveland JL; O'Brien TG
Cancer Res; 2005 Feb; 65(4):1146-9. PubMed ID: 15734996
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase Cdelta-mediated signal to ornithine decarboxylase induction is independent of skin tumor suppression.
Wheeler DL; Reddig PJ; Dreckschmidt NE; Leitges M; Verma AK
Oncogene; 2002 May; 21(22):3620-30. PubMed ID: 12032864
[TBL] [Abstract][Full Text] [Related]
4. Targeted antizyme expression in the skin of transgenic mice reduces tumor promoter induction of ornithine decarboxylase and decreases sensitivity to chemical carcinogenesis.
Feith DJ; Shantz LM; Pegg AE
Cancer Res; 2001 Aug; 61(16):6073-81. PubMed ID: 11507056
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the development of metastatic squamous cell carcinoma in protein kinase C epsilon transgenic mice by alpha-difluoromethylornithine accompanied by marked hair follicle degeneration and hair loss.
Wheeler DL; Ness KJ; Oberley TD; Verma AK
Cancer Res; 2003 Jun; 63(12):3037-42. PubMed ID: 12810623
[TBL] [Abstract][Full Text] [Related]
6. Involvement of protein kinase C activation in ornithine decarboxylase gene expression in primary culture of newborn mouse epidermal cells and in skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
Verma AK; Pong RC; Erickson D
Cancer Res; 1986 Dec; 46(12 Pt 1):6149-55. PubMed ID: 3779635
[TBL] [Abstract][Full Text] [Related]
7. Correlation of phorbol ester promotion in the resistant C57BL/6J mouse with sustained hyperplasia but not ornithine decarboxylase or protein kinase C.
Fischer SM; Jasheway DW; Klann RC; Butler AP; Patrick KE; Baldwin JK; Cameron GS
Cancer Res; 1989 Dec; 49(23):6693-9. PubMed ID: 2819717
[TBL] [Abstract][Full Text] [Related]
8. Xanthorrhizol inhibits 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation and two-stage mouse skin carcinogenesis by blocking the expression of ornithine decarboxylase, cyclooxygenase-2 and inducible nitric oxide synthase through mitogen-activated protein kinases and/or the nuclear factor-kappa B.
Chung WY; Park JH; Kim MJ; Kim HO; Hwang JK; Lee SK; Park KK
Carcinogenesis; 2007 Jun; 28(6):1224-31. PubMed ID: 17234720
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
[TBL] [Abstract][Full Text] [Related]
10. Promotion of skin carcinogenesis by dimethylarsinic acid in keratin (K6)/ODC transgenic mice.
Morikawa T; Wanibuchi H; Morimura K; Ogawa M; Fukushima S
Jpn J Cancer Res; 2000 Jun; 91(6):579-81. PubMed ID: 10874208
[TBL] [Abstract][Full Text] [Related]
11. Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin.
O'Brien TG; Megosh LC; Gilliard G; Soler AP
Cancer Res; 1997 Jul; 57(13):2630-7. PubMed ID: 9205069
[TBL] [Abstract][Full Text] [Related]
12. The utility of the K6/ODC transgenic mouse as an alternative short term dermal model for carcinogenicity testing of pharmaceuticals.
Miller TJ; Honchel R; Espandiari P; Knapton A; Zhang J; Sistare FD; Hanig JP
Regul Toxicol Pharmacol; 2008 Feb; 50(1):87-97. PubMed ID: 18069108
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of ornithine decarboxylase (ODC) decreases tumor vascularization and reverses spontaneous tumors in ODC/Ras transgenic mice.
Lan L; Trempus C; Gilmour SK
Cancer Res; 2000 Oct; 60(20):5696-703. PubMed ID: 11059762
[TBL] [Abstract][Full Text] [Related]
14. Polyamines modulate carcinogen-induced mutagenesis in vivo.
Wallon UM; O'Brien TG
Environ Mol Mutagen; 2005; 45(1):62-9. PubMed ID: 15611981
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of a dominant-negative ornithine decarboxylase in mouse skin: effect on enzyme activity and papilloma formation.
Shantz LM; Guo Y; Sawicki JA; Pegg AE; O'Brien TG
Carcinogenesis; 2002 Apr; 23(4):657-64. PubMed ID: 11960919
[TBL] [Abstract][Full Text] [Related]
16. Regulation of ornithine decarboxylase gene expression in mouse epidermis and epidermal tumors during two-stage tumorigenesis.
Gilmour SK; Verma AK; Madara T; O'Brien TG
Cancer Res; 1987 Mar; 47(5):1221-5. PubMed ID: 3815331
[TBL] [Abstract][Full Text] [Related]
17. Mouse skin chemical carcinogenesis is inhibited by antizyme in promotion-sensitive and promotion-resistant genetic backgrounds.
Feith DJ; Shantz LM; Shoop PL; Keefer KA; Prakashagowda C; Pegg AE
Mol Carcinog; 2007 Jun; 46(6):453-65. PubMed ID: 17219416
[TBL] [Abstract][Full Text] [Related]
18. Enhanced induction of epidermal ornithine decarboxylase activity in C57BL/6 compared to DBA/2 mice by protein kinase C-activating skin tumor promoters: relevance to genetically mediated differences in promotion susceptibility.
Imamoto A; Beltrán LM; Fujiki H; Chenicek KJ; DiGiovanni J
Carcinogenesis; 1992 Feb; 13(2):177-82. PubMed ID: 1740006
[TBL] [Abstract][Full Text] [Related]
19. Ornithine decarboxylase expression in cutaneous papillomas in SENCAR mice is associated with altered expression of keratins 1 and 10.
Sundberg JP; Erickson AA; Roop DR; Binder RL
Cancer Res; 1994 Mar; 54(5):1344-51. PubMed ID: 7509717
[TBL] [Abstract][Full Text] [Related]
20. Deregulation of polyamine biosynthesis alters intrinsic histone acetyltransferase and deacetylase activities in murine skin and tumors.
Hobbs CA; Paul BA; Gilmour SK
Cancer Res; 2002 Jan; 62(1):67-74. PubMed ID: 11782361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
